Product Information
ALCLOMETASONE DIPRO 0.05% CRM is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $1.5681 per GM under NDC 51672130606. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Sep 15, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672130606
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
ALCLOMETASONE DIPROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA076587FDA Approved
9/15/2005
TE Code
AB
On Market Since
9/15/2005
Pharmacological Classes
Price Statistics
The NADAC for ALCLOMETASONE DIPRO 0.05% CRM has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 14.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.5681 per GM |
|---|---|
| All-time high | $1.6460 (Mar 16, 2016) |
| All-time low | $0.5352 (Oct 18, 2023) |
| 52-week high | $1.5681 |
| 52-week low | $0.5518 |
| Median price | $1.2473 |
| Average price | $1.1411 |
| Largest weekly change | +135.6% (Oct 22, 2025) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Alclometasone dipropionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Alclometasone dipropionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ALCLOMETASONE DIPRO 0.05% CRM?
The current National Average Drug Acquisition Cost (NADAC) for ALCLOMETASONE DIPRO 0.05% CRM, manufactured by Sun Pharmaceutical Industries Inc., is $1.5681 per GM (NDC 51672130606), effective Sep 30, 2026.
How has the price of ALCLOMETASONE DIPRO 0.05% CRM changed over time?
Over the history we have for it, the NADAC for ALCLOMETASONE DIPRO 0.05% CRM has risen 14.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALCLOMETASONE DIPRO 0.05% CRM?
Since Nov 28, 2013, the NADAC for ALCLOMETASONE DIPRO 0.05% CRM has ranged from a low of $0.5352 (Oct 18, 2023) to a high of $1.6460 (Mar 16, 2016), with a median of $1.2473 per GM.
Are there cheaper alternatives to ALCLOMETASONE DIPRO 0.05% CRM?
No other NADAC-published product currently shares the active ingredient and strength of ALCLOMETASONE DIPRO 0.05% CRM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ALCLOMETASONE DIPRO 0.05% CRM?
ALCLOMETASONE DIPRO 0.05% CRM (NDC 51672130606) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.